Title: The Prognostic Role of the AST/ALT Ratio in Hepatocellular carcinoma Patients
Receiving Thermal Ablation Combined with Simultaneous TACE
Version: 0 Date: 19 Feb 2023
Reviewer's report:
This is a retrospective, single-center study investigating the prognostic value of aspartate
transaminase (AST)/alanine transaminase (ALT) ratio in hepatocellular carcinoma (HCC)
patients undergoing same-session RFA or MWA and TACE.
Advantages: The manuscript is well-written and the outcomes are supported by the
methodology. It is a valuable addition to the literature.
Disadvantages: Retrospective, single-center, with limited number of patiens. These limitations
are correctly reported by the authors.
General comments:
1. Some grammatical errors are found in the text. The authors should proofread the manuscript.
2. How were the variables for univariate analysis selected?
3. How the follow-up times were chosen
4. The exclusion criteria might be more detailed
5. Please briefly describe and explain how to build the nomogram model.
Title: The Prognostic Role of the AST/ALT Ratio in Hepatocellular carcinoma Patients
Receiving Thermal Ablation Combined with Simultaneous TACE
Version: 0 Date: 19 Feb 2023
Reviewer's report:
This is a retrospective, single-center study investigating the prognostic value of aspartate
transaminase (AST)/alanine transaminase (ALT) ratio in hepatocellular carcinoma (HCC)
patients undergoing same-session RFA or MWA and TACE.
Advantages: The manuscript is well-written and the outcomes are supported by the
methodology. It is a valuable addition to the literature.
Disadvantages: Retrospective, single-center, with limited number of patiens. These limitations
are correctly reported by the authors.
General comments:
1. Some grammatical errors are found in the text. The authors should proofread the manuscript.
2. How were the variables for univariate analysis selected?
3. How the follow-up times were chosen
4. The exclusion criteria might be more detailed
5. Please briefly describe and explain how to build the nomogram model.
Please review this paper.
user
Title: The Prognostic Role of the AST/ALT Ratio in Hepatocellular carcinoma Patients
Receiving Thermal Ablation Combined with Simultaneous TACE
Version: 0 Date: 19 Feb 2023
Reviewer's report:
This is a retrospective, single-center study investigating the prognostic value of aspartate
transaminase (AST)/alanine transaminase (ALT) ratio in hepatocellular carcinoma (HCC)
patients undergoing same-session RFA or MWA and TACE.
Advantages: The manuscript is well-written and the outcomes are supported by the
methodology. It is a valuable addition to the literature.
Disadvantages: Retrospective, single-center, with limited number of patiens. These limitations
are correctly reported by the authors.
General comments:
1. Some grammatical errors are found in the text. The authors should proofread the manuscript.
2. How were the variables for univariate analysis selected?
3. How the follow-up times were chosen
4. The exclusion criteria might be more detailed
5. Please briefly describe and explain how to build the nomogram model.
assistant